Vanguard Group’s Vincerx Pharma VINC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-14,317
Closed -$7.57K – 4374
2025
Q1
$7.57K Sell
14,317
-2
-0% -$3 ﹤0.01% 4263
2024
Q4
$75.3K Sell
14,319
-17,053
-54% -$112K ﹤0.01% 4186
2024
Q3
$449K Hold
31,372
– – ﹤0.01% 4001
2024
Q2
$508K Sell
31,372
-1,978
-6% -$49.6K ﹤0.01% 3996
2024
Q1
$3.37M Buy
33,350
+7,679
+30% +$485K ﹤0.01% 3433
2023
Q4
$606K Hold
25,671
– – ﹤0.01% 3977
2023
Q3
$519K Sell
25,671
-342
-1% -$6.63K ﹤0.01% 4042
2023
Q2
$676K Hold
26,013
– – ﹤0.01% 4026
2023
Q1
$541K Hold
26,013
– – ﹤0.01% 4107
2022
Q4
$531K Sell
26,013
-95
-0.4% -$1.79K ﹤0.01% 4081
2022
Q3
$720K Sell
26,108
-2,863
-10% -$82.4K ﹤0.01% 4101
2022
Q2
$765K Sell
28,971
-4,330
-13% -$193K ﹤0.01% 4172
2022
Q1
$2.66M Buy
33,301
+583
+2% +$72K ﹤0.01% 3834
2021
Q4
$6.67M Buy
32,718
+5,966
+22% +$1.49M ﹤0.01% 3450
2021
Q3
$8.65M Buy
26,752
+2,749
+11% +$802K ﹤0.01% 3335
2021
Q2
$6.24M Buy
24,003
+4,504
+23% +$1.37M ﹤0.01% 3475
2021
Q1
$7.53M Buy
+19,499
New +$7.87M ﹤0.01% 3315

Other funds holding VINC

Vanguard Group's VINC Position: Q2 2025 in Review

Vanguard Group sold out of Vincerx Pharma (VINC) in Q2 2025, closing a stake of 14,317 shares — an estimated $7.57K sold.

Vanguard Group first reported a position in VINC in Q1 2021 and held it in 17 quarters. The position peaked at $8.65M in Q3 2021. 1 fund tracked by Wall St. Rank holds VINC as of Q2 2025.

  • Vanguard Group reported no remaining Vincerx Pharma position as of Q2 2025 after selling out during the quarter.
  • Vanguard Group sold 14,317 Vincerx Pharma shares in Q2 2025, an estimated $7.57K.
  • Vanguard Group first reported a position in Vincerx Pharma in Q1 2021 and held it in 17 quarters.
  • Vanguard Group's Vincerx Pharma position peaked at $8.65M in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Vincerx Pharma as of Q2 2025.

Based on Vanguard Group's 13F filing for Q2 2025, filed 11 Aug 2025.